Schuur et al create a top-five list of tests, treatments, and disposition decisions that are of little value, are amenable to standardization, and are actionable by emergency medicine clinicians.
This secondary analysis of a randomized clinical trial assesses the effect of pharmacologic therapy and clinical risk factors on incident conduction system disease in patients with hypertension.
This population epidemiology study uses US Renal Data System data to characterize emergency department (ED) visits, hospitalizations from the ED, and demographic characteristics of patients with end-stage renal disease who used ED services between 2005 and 2011.
Among drug-using emergency department patients, Bogenschutz and colleagues contrast the effects of a brief intervention with telephone boosters with those of (1) screening, assessment, and referral to treatment and (2) minimal screening only, finding that even a relatively robust brief intervention did not improve substance use outcomes.
This retrospective analysis of testing strategies for patients with chest pain evaluated in the ED finds that deferral of early noninvasive testing appears to be reasonable.
This difference-in-difference quasi-experimental study found that granting states permission to collect copayments for nonurgent visits under the Deficit Reduction Act of 2005 did not significantly change ED or outpatient medical provider use among Medicaid beneficiaries. See the Invited Commentary by Baicker and Levy.
This retrospective study of ED visits by adults shows that cardiac biomarker testing in the ED is common even among those without symptoms suggestive of acute coronary syndrome.